KennedyJ.L., RobinsonD., ChristophelJ.Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.Am J Rhinol Allergy28: 59–64, 2014.
2.
PokladnikovaJ., KrcmovaI., and VlcekJ.Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.Ann Allergy Asthma Immunol100: 482–489, 2008.
3.
ParkD., DaherN., and BlaissM.S.Adult and pediatric clinical trials of sublingual immunotherapy in the USA.Expert Rev Clin Immunol8: 557–564, 2012.
4.
BertoP., FratiF., and IncorvaiaC.Economic studies of immunotherapy: A review.Curr Opin Allergy Clin Immunol8: 585–589, 2008.
5.
RønborgS.M., SvendsenU.G., MicheelsenJ.S.Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis.Clinicoecon Outcomes Res4: 253–260, 2012.
